CDC projected JN.1 variant of SARS-CoV-2 to account for 39-50% of circulating variants in the U.S.

,

On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) projected the JN.1 variant of SARS-CoV-2 to account for 39-50% of circulating variants in the U.S. The CDC continued to track JN.1 and other emerging variants, in close collaboration with partners around the world.

Tags:


Source: U.S. Centers for Disease Control and Prevention
Credit:

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.